# Tigecycline

NDC: 70121-1647
Generic name: Tigecycline
Labeler / Manufacturer: Amneal Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180131

FDA application: NDA211158

## Active ingredients

- TIGECYCLINE: 50 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70121-1647"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70121-1647
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8450bd15-2b06-4fc7-b302-9021312e3f0d